West-Ward Pharmaceutical clinical trials
Acquired by Hikma Pharmaceuticals
The registry lists 4 studies whose lead sponsor is West-Ward Pharmaceutical. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 23, 2024.
Registry sponsor names on this page
- West-Ward Pharmaceutical4 studies
Something wrong with this grouping? Tell us on the Hikma Pharmaceuticals page.
Studies
Recruiting first, then most recently updated. Showing 4 of 4. All Hikma Pharmaceuticals studies →
- Study to Determine the Pharmacokinetics and Pharmacodynamic Effects of Phenylephrine on BP Via IVRecruitingNCT02323399Phase 4
Sponsor listed in the registry: West-Ward Pharmaceutical · West-Ward Pharmaceutical — acquired company within the Hikma Pharmaceuticals group
- Clinical Endpoint Bioequivalence Study of Fluticasone Propionate & Salmeterol Xinafoate (100μg/50μg)CompletedNCT03535870Not applicable
Sponsor listed in the registry: West-Ward Pharmaceutical · West-Ward Pharmaceutical — acquired company within the Hikma Pharmaceuticals group
- Study of Oral Morphine Sulfate Administration in Pediatric SubjectsCompletedNCT03429400Phase 3
Sponsor listed in the registry: West-Ward Pharmaceutical · West-Ward Pharmaceutical — acquired company within the Hikma Pharmaceuticals group
- Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset SeizuresCompletedNCT01284556Phase 3
Sponsor listed in the registry: West-Ward Pharmaceutical · West-Ward Pharmaceutical — acquired company within the Hikma Pharmaceuticals group